Skip to Late-Breaking Abstracts »
All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.
Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).
# | Title | Authors | Category | Keywords |
---|---|---|---|---|
O65 | Artificial intelligence-powered retrospective analysis of PD-L1 expression in nivolumab trials of advanced non-small cell lung cancer | Vipul Baxi, MS; Andrew Beck, MD, PhD; Dimple Pandya; George Lee, PhD; Cyrus Hedvat, MD, PhD; Aditya Khosla; Dayong Wang; Hunter Elliott; Harsha Pokkalla; Abhik Lahiri; Benjamin Glass; Jennifer K. Kerner; Ilan Wapinski; Scott D. Chasalow; Han Chang, PhD; Robin H. Edwards, PhD; Michael Montalto; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Inflammation; Monocyte/Macrophage |
P726 | Applying deep learning classification for tumor identification across immunohistochemical markers on serial sections to eliminate the need for image co-registration | Mark Anderson, BSc; Karen McClymont; Lorcan Sherry, PhD; Alison Bigley, CSci, FIBMS; | Machine Learning, Artificial Intelligence, and Computational Modeling | Biomarkers; Immune contexture; T cell; Tumor microenvironment; Tumor stroma |
P727 | Single-cell systems neuroimmunology reveals immunosuppressive checkpoint blockade receptor expression correlates with ventricular stem cell niche contact in human glioblastoma | Todd Bartkowiak, PhD; Sierra Barone, BS.; Allison R. Greenplate, PhD; Justine Sinnaeve, BS.; Nalin Leelatian; Akshitkumar M. Mistry, MD; Caroline E. Roe, BS.; Bret C. Mobley, MD; Lola B. Chambless, MD; Reid C. Thompson, MD; Kyle D. Weaver, MD; Rebecca A. Ihrie, PhD; Jonathan M. Irish, PhD; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Immune monitoring; Immune suppression; Monocyte/Macrophage; Myeloid cells; Solid tumors; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment |
P728 | Inference of immunotherapy response-predictive biomarkers in lung adenocarcinoma from hematoxylin and eosin (H&E) stained images | Kimary Kulig, PhD, MPH; Cory Batenchuk, PhD; Peter Cimermancic; Huang-Wei Chang, PhD; Eunhee S. Yi, MD; Vanessa A. Velez; Hardik L. Patel; Ali Behrooz; Kamilla Tekiela; Robert Findlater; Cory Batenchuk, PhD; | Machine Learning, Artificial Intelligence, and Computational Modeling | Biomarkers; Checkpoint blockade; Tumor microenvironment |
P730 | An empirical framework for validating artificial intelligence-derived PD-L1 positivity predictions using samples from patients with urothelial carcinoma | Andrew Beck, MD, PhD; Benjamin Glass; Hunter Elliott; Jennifer K. Kerner; Aditya Khosla; Abhik Lahiri; Harsha Pokkalla; Dayong Wang; Ilan Wapinski; George Lee, PhD; Vipul Baxi, MS; Cyrus Hedvat, MD, PhD; Dimple Pandya; Michael Montalto; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Inflammation; Monocyte/Macrophage |
P731 | Identification and Validation of Shared Neoantigens for Cancer Immunotherapy | Jennifer Busby, PhD; Melissa Rotunno; Tyler Murphy; William Brinton; Michael Zhong; Lina Kim; Abu Jalloh; Amanda Costa; Michael Fray; Aaron Yang; Meghan Hart; Matthew Davis; Rita Zhou; Elizabeth Maloney; Alexis Mantila; Karin Jooss, PhD; Aleksandra Nowicka; Christine D. Palmer, PhD; James Sun; Roman Yelensky, PhD; Jennifer Busby, PhD; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Neoantigens; Proteomics |
P732 | Reverse causal inferencing on lung adenocarcinoma patients reveals a stem cell-like molecular subtype associated with pack year history | Renee M. Deehan; Sergey Korkhov; Alexis Foroozan; Scott Marshall, Ph.D; Renee M. Deehan; Nimisha Schneider; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Checkpoint blockade; Solid tumors |
P733 | Quantitative systems pharmacology modeling of B-cell acute lymphoblastic leukemia treatment with bispecific T-cell engaging antibodies for investigation of bell-shaped dose response | Oleg Demin Jr, MSc; | Machine Learning, Artificial Intelligence, and Computational Modeling | Antibody; Leukemia/Lymphoma; Systems biology; T cell |
P734 | Prediction of target occupancy in tumor after treatment with anti-PD1 antibodies using physiologically based pharmacokinetic modeling | Oleg Demin Jr, MSc; Dmitry Shchelokov; | Machine Learning, Artificial Intelligence, and Computational Modeling | Antibody; Checkpoint blockade; T cell |
P735 | Accelerating biomarker discovery using AI powered multi- omics approaches | Madhuri Gadekar; Mohan Uttarwar; Shruti Desai; Sanjay Khare; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Clinical trial; Immune monitoring; Immunoscore |
P736 | Combining Multiplexed Ion Beam Imaging (MIBI) with Convolutional Neural Networks to accurately segment cells in human tissue | Noah F. Greenwald, BA; Leeat Keren; Shirley Greenbaum; Mara Fong; Gautam Chaudhry; Zion Abraham; Jackson Moseley; David Van Valen; Michael Angelo, MD, PhD; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Solid tumors; Tumor microenvironment; Tumor stroma |
P737 | Model-Based Meta-Analysis of the Exposure-Response and Clinical Efficacy across Approved Anti-PD(L)1 Agents | Apurvasena Parikh, PhD; Sreeneeranj Kasichayanula, PHD; Rajeev Menon; Megan Gibbs; Sven Mensing; Benjamin Engelhardt; | Machine Learning, Artificial Intelligence, and Computational Modeling | Antibody; Checkpoint blockade; Solid tumors |
P738 | Artificial intelligence-based tumor purity assessment of digitized histology samples in multiple tumor types from clinical trials of nivolumab | George Lee, PhD; Sujaya Srinivasan; Natallia Kalinava; Ariella Sasson; Vipul Baxi, MS; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Clinical trial; Tumor stroma |
P739 | Analysis of H&E Images Using Deep Learning for the Prediction of Distant Metastatic Recurrence in Early Stage Melanoma | Michael R. Moore, BA; Eric J. Robinson, BA; Prathamesh M. Kulkarni, PhD; Robyn Gartrell, MD; Jaya Pradhan, DMD, MPH; Emanuelle M. Rizk, BA; Chen Yang, MD; Acs Balazs, PhD; Robert Phelps, MD; Tammie Ferringer, MD; Andrew X. Chen, BS; Raúl Rabadán, PhD; Bethany Rohr, MD; Basil A. Horst, MD; David L. Rimm, MD, PhD; Jing Wang, MD; Yvonne Saenger, MD; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Solid tumors; T cell; Tumor microenvironment; Tumor stroma |
P740 | Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development using Functional Ex-Vivo 3D-Tumor Organoid Platforms of Fresh Patient Tissue Samples. | Jenny Kreahling, PhD; Daniel N. Santiago, PhD; Vijayendra Agrawal, PhD; Mibel Pabon, PhD; Soner Altiok, MD, PhD; Melba Page, PhD; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Checkpoint blockade; Gene expression; Immune monitoring; Solid tumors; Systems biology; T cell; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment |
P741 | Prediction of biomarkers and combinational therapies for anti-PD1 therapy using a computational network approach | Chia Chin Wu, PhD; Andrew Futreal; Jianhua Zhang; Chia-Chin Wu; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Carcinogenesis; Checkpoint blockade; Immune suppression; Immunoscore; Systems biology; Targeted therapy |
P742 | Computational analysis of feedback regulations of TIM-3 | Jian Zhu, PhD; Rebecca L. Zhu; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Checkpoint blockade; Regulatory T cell (Treg cell); Systems biology |
P743 | Impact of IDO1 expression and inhibition on the sensitivity of anti-PD-1 | Jian Zhu, PhD; Rebecca L. Zhu; | Machine Learning, Artificial Intelligence, and Computational Modeling | Bioinformatics; Biomarkers; Checkpoint blockade; Systems biology |